Abattis Bioceuticals Corp.
Abattis Bioceuticals Corp. (ATTBF) Shares Outstanding — Overview
Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.
ATTBF · shares outstanding · updated Jun 9, 2026
Key metrics
as of Sep 30, 2019Shares Outstanding Growth Rate
CAGR · weighted avg basic sharesNegative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials
Shares outstanding history
Annual shares outstanding by year
Healthcare sector shares outstanding comparison
Shares Outstanding for similar companies or competitors in the Healthcare sector.
MRK
JNJ
ABBV
AZN
UNH
LLYATTBF/company-screener · per-peer /income-statement · cache 86400s
Understanding Shares Outstanding
Basic · Diluted · FloatWhat Are Shares Outstanding? (Basic)
Abattis Bioceuticals Corp. (ATTBF) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of September 30, 2019, Abattis Bioceuticals Corp. reports 470.5M basic shares outstanding (weighted average).
Basic vs. Diluted Shares Outstanding
Abattis Bioceuticals Corp.'s basic shares outstanding (470.5M) represents currently issued shares. Diluted shares outstanding (470.5M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.
Shares Outstanding vs. Float (Free Float)
Abattis Bioceuticals Corp.'s float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.
ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.
FMP /income-statement · /shares-float · SEC EDGAR · CAD
About shares outstanding & methodology
Abattis Bioceuticals Corp. (ATTBF) shares outstanding history from 2008 to 2019. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.
Abattis Bioceuticals Corp. shares outstanding for the fiscal year ending September 30, 2019 were 470.5M, a 45.83% increase year-over-year. Abattis Bioceuticals Corp. FY 2019 shares outstanding were 470.5M, a +45.83% increase from FY 2018.
Abattis Bioceuticals Corp. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +113.2% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.
Frequently asked questions
ATTBF shares outstanding · 4 questionsAs of September 30, 2019, Abattis Bioceuticals Corp. (ATTBF) has approximately 470.5M basic shares outstanding and 470.5M diluted shares outstanding. This represents a +45.83% year-over-year increase from FY 2018 (322.6M). The increase may reflect equity compensation issuances or secondary offerings.
▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Abattis Bioceuticals Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09